Introduction
Chromosomal region 9p21 is frequently deleted in many tumour types (Cairns et al., 1994; Fountain et al., 1992; Weaver-Feldhaus et al., 1994) including melanoma and although several genes have been localised to this chromosomal region, the CDKN2A gene which encodes the cyclin dependent kinase inhibitor, p16 INK4a , has been implicated as the critical 9p21 target (Cairns et al., 1995; Kamb et al., 1994a; Nobori et al., 1994; Spruck et al., 1994) . p16
INK4a controls cell cycle proliferation during G1 by inhibiting the ability of cyclin dependent kinase (CDK) 4/ Cyclin D and CDK6/Cyclin D complexes to phosphorylate pRb (Serrano et al., 1993) . The role of p16
INK4a as a broad tumour suppressor has been con®rmed with the identi®cation of mutations in DNA obtained from pancreatic adenocarcinoma (Caldas et al., 1994) and esophageal carcinoma (Igaki et al., 1995) tumour samples and by the tumour-prone phenotype of p16 INK4a -de®cient mice (Serrano et al., 1996) . The CDKN2A gene is also frequently silenced by hypermethylation in many primary tumours, including breast, colon and non-small cell lung carcinomas (Gonzalez-Zulueta et al., 1995; Herman et al., 1995; Merlo et al., 1995) . Furthermore, mutations that impair the function of this gene have been found to segregate with cutaneous melanoma in at least one-half of all chromosome 9p-linking hereditary melanoma kindreds studied (Ohta et al., 1994; Kamb et al., 1994b; Hussussian et al., 1994; Liu et al., 1995; Gruis et al., 1995; Holland et al., 1995; Walker et al., 1995; Borg et al., 1996) .
There remains however a subset of chromosome 9p-linked melanoma families with no detectable exonic mutations in the CDKN2A gene (Hussussian et al., 1994; Kamb et al., 1994b; Holland et al., 1995) . Melanoma susceptibility in these families may be due to undetected mutations in the CDKN2A untranslated regions aecting either its expression or mRNA stability. Alternatively, melanoma may not truly be linked to 9p in some of these families or, in some, mutations in a closely linked second chromosome 9p21 gene may predispose to melanoma development. The gene encoding the alternate p16
INK4a transcript, p16b, has growth-inhibitory properties and is an important candidate gene for melanoma susceptibility. This transcript consists of a novel exon 1b sequence spliced onto the CDKN2A exons 2 and 3 . The p16b transcript contains a large open reading frame which is read in a dierent frame to that of the p16
INK4a transcript , and although the protein has not been identi®ed in human cells , the murine p16b transcript (also known as p19 ARF ) encodes a 19 kDa protein that shares no homology to p16
INK4a but is able to induce G1 and G2 growth arrest in rodent ®broblasts (Quelle et al., 1995) . The human homologue, p16b, also induces G1 cell cycle arrest in head and neck squamous carcinoma cell lines and HeLa cell lines (Liggett et al., 1996) . Although exon 1b mutations have not been found in hereditary melanoma families FitzGerald et al., 1996) , the role of p16b in melanoma predisposition has not been well studied. Small deletions abolishing p16b and not p16 INK4a expression have been reported in three independent melanoma cell lines Stone et al., 1995) . Further, although the p16
INK4a and p16b transcripts are generated from unique promoters both are coordinately regulated by pRb (Hara et al., 1996) . The role of p16
INK4a in familial melanoma has been well established and a regulatory link with this melanoma tumour suppressor indicates that the function of p16b needs to be thoroughly assessed.
In this study the expression of p16
INK4a and p16b was examined in eight Australian familial melanoma kindreds, including three putatively 9p-linked families (Nancarrow et al., 1993; Holland et al., 1995) . The families selected did not carry any disease-related CDKN2A mutations, but some members were informative for one of two known CDKN2A polymorphisms (Holland et al., 1995) . The presence of these polymorphisms permitted a detailed analysis of CDKN2A and p16b expression. The expression of both genes from their respective alleles was determined and compared. Our ®ndings indicate that CDKN2A and p16b expression is regulated in an allele speci®c manner. Furthermore, the disruption of this regulation was observed in three melanoma aected individuals from two putatively 9p-linking families, indicating that deregulated expression of p16
INK4a and its alternate transcript may be an alternative genetic means for melanoma susceptibility. This is the ®rst report implicating p16b in familial melanoma predisposition.
Results

Screening for p16
INK4a and p16b polymorphisms
Allele speci®c expression analysis involves amplifying speci®c cDNA and determining the proportion of ampli®ed product originating from each allele. This requires the separation and identi®cation of the product derived from each allele. At least two polymorphisms, one in the p16 INK4a exon 2 (G 482 A; Ala148Thr) and one in exon 3 (C 580 T), could be used to distinguish the p16
INK4a allelic messages. The same polymorphisms also permitted separation of the p16b allelic products, since exons 2 and 3 are shared by both p16 genes . For this study over 80 individuals from 10 large Australian familial melanoma kindreds were screened for the G 482 A and C 580 T polymorphism using temperature gradient gel electrophoresis (TGGE), sequencing and/or HaeIII restriction enzyme digestion (the HaeIII digestion was only used for detecting the C 580 T polymorphism). The results of this screen are summarised in Table 1 . From this survey 32 individuals heterozygous for either the exon 2 or exon 3 polymorphism were identi®ed. Of these, 18 were analysed for allele-speci®c expression of p16 INK4a and p16b and the results are presented in this study. The majority of the remaining heterozygous individuals could not be analysed because EBV-transformed lymphoblastoid cell lines were not available and peripheral blood lymphocytes did not express p16
INK4a
(data not shown).
p16
INK4a and p16b allele speci®c expression
Total RNA was isolated from EBV-transformed lymphoblastoid cell lines from individuals who were heterozygous at either the polymorphic G 482 A site in exon 2 or the C 580 T site in exon 3. The allele speci®c expression method applied in this study is summarised in Figure 1 . Brie¯y, the region spanning both polymorphic sites was ampli®ed in a PCR reaction incorporating [a 33 P]dATP after reverse transcription using an exon 3-speci®c oligonucleotide. Two PCR products were generated in separate PCR reactions from each individual using 5' primers speci®c for either exon 1 or exon 1b to yield a 562 bp p16
INK4a product or a 706 bp p16b PCR product. Homoduplexes of radioactively labelled PCR product from each allele were separated using TGGE and the band intensity of each allele was measured.
Allelic expression of p16 INK4a and p16b was measured in duplicate, usually on three independent RNA preparations from each of 18 lymphoblastoid cell lines. These were derived from: (i) eight informative individuals from three kindreds (20008, 20963 and 21065) in which a 9p haplotype¯anking the CDKN2A region co-segregated with melanoma (Holland et al., 1995) (Figure 2); and (ii) ten individuals from ®ve kindreds (20050, 21273, 21388, 21579 and 21137) in which no 9p haplotype linked to melanoma susceptibility could be assigned.
The level of p16 INK4a transcript arising from the common allele of CDKN2A (i.e. the allele most common in the population which contains a G at nucleotide position 482 and a C at position 580; see Figure 1 ) was expressed as a proportion of the total p16
INK4a expression (Table 2) ; allele-speci®c levels of p16b transcripts were calculated in the same way. The expression of the common p16 (Table 2 ). In 11 of 18 individuals both p16
INK4a alleles expressed approximately equally (Table 2) . A similar pattern of expression was observed for the p16b transcripts. The range of expression for the common p16b allele ranged from 0.25 to 0.71 and 12 of 18 individuals expressed p16b alleles equally (Table 2) .
To study the relationship between p16 INK4a and p16b transcript levels the relative expression of the p16 INK4a common allele and p16b common allele was compared and p16b alleles on the same parental chromosome (i.e. lying in cis) was coordinate, so that predominance of one allele of p16 INK4a was accompanied by predominance of the same p16b allele. This is illustrated by 058 (Figure 3 ), in which one parental allele of both p16 INK4a and p16b was expressed more than twice as strongly as the other allele (ratios 0.78 and 0.71, respectively, i.e. the common allele dominated). Similarly, in 1179, expression of one parental allele was about half that of the other allele for both p16
INK4a and p16b (ratios 0.38 and 0.35 respectively, i.e. the common allele was underexpressed). The positive correlation between the expression of p16
INK4a and p16b is illustrated in Figure 3 . Three individuals deviated from this coordinate pattern (Figure 3 ). In these cases (006, 673, 958), p16b expression from the chromosome bearing the common CDKN2A allele was lower than the expression of the same p16
INK4a allele (p16 INK4a p16b ratio for 006, 673, 958: 0.65/0.26, 0.48/0.28, 0.38/0.25, respectively). Expression of p16 INK4a and p16b was thus not coordinated in these individuals. Figure 2 shows that in the two kindreds with these three individuals (20008, 20963) , the parental chromosome bearing the common CDKN2A allele, and therefore relatively underexpressing the p16b transcript, co-segregates with melanoma susceptibility. None of the other aected members from these two families could be tested (i.e. none carried the polymorphisms required for allele-speci®c expression analysis).
To con®rm that p16b expression from one allele was reduced, p16b cDNA was ampli®ed and sequenced from the three heterozygous individuals in kindred 20963 (672, 673, 958). As shown in Figure 4 , the INK4a and p16b allele-speci®c expression. Two polymorphic sites at nucleotide positions 482 and 580 are indicated by asterisks. c and p refer to the two p16
INK4a and p16b alleles and the c allele, with a G at nucleotide position 482 and C at position 580, is referred to as the common allele throughout this study. The p16 INK4a speci®c PCR primers (123A and 3B) and the p16b speci®c PCR primers (p16b.fwd and 3B) are also shown The boxed haplotype segregates with melanoma susceptibility. CDKN2A genotype is indicated beside D9S942 as common (G 482 , C 580 ) allele (c), or a polymorphic variant (p). Age of onset of melanoma, or last age at which known to be unaected, is indicated. All known aecteds and all individuals informative for the CDKN2A polymorphisms are shown 
Analysis of p16
INK4a and p16b methylation status
To determine whether allele expression dierences between p16 INK4a and p16b were due to methylation of the gene(s) we characterised the expression of both genes following treatment with 1 mM 5-aza 2'deoxycytidine for 48 ± 72 h (Otterson et al., 1995) . In three cell lines 672, 006 and 058 no change in the ratio of p16
INK4a and p16b allele messages was observed (data not shown).
Sequence of exon 1b
The CDKN2A exons have been previously sequenced for the eight melanoma kindreds used in this study; apart from the reported polymorphisms, no other change was detected (Holland et al., 1995) . To rule out the possibility that exonic mutations in exon 1b aected its expression, this exon was ampli®ed from the genomic DNA isolated from either blood or EBV-transformed cell lines derived from the following individuals: 672, 673, 006, 958 and 058. The PCR products were puri®ed and sequenced using exon 1b intronic primers. Compared to the published sequence several homozygous intronic nucleotide changes were identi®ed in each of the ®ve individuals, as well as in two additional unrelated DNA samples, representing a total of 11 independent chromosomes ( Figure 5 ). These therefore represent corrections to the published exon 1b genomic sequence. No exonic mutations were found, nor any change unique to the individuals showing uncoordinated expression of the p16
INK4a and p16b transcripts.
Discussion
Since its localisation to chromosome 9p21, the cellcycle regulator gene CDKN2A has become the focus of mutation screening in familial melanoma kindreds. As a result some 20 melanoma-prone families have been reported to carry disease-associated CDKN2A muta- tions (Nancarrow et al., 1993; Ohta et al., 1994; Hussussian et al., 1994; Kamb et al., 1994b; Gruis et al., 1995; Holland et al., 1995; Liu et al., 1995; Walker et al., 1995; Borg et al., 1996) . Furthermore an expression defect in this gene, although not characterised, has been reported in one melanoma-prone family (Ranade et al., 1995) . In our 17 large Australian melanoma kindreds, six of which show evidence of linkage to chromosome 9p21 only one family carried an exonic CDKN2A mutation segregating with the disease (Holland et al., 1995) . The possibility remains, however, that alterations aecting the stability, expression and/or the translocation of this gene and its product may be responsible for melanoma predisposition in some 9p21-linking families. The identi®cation of polymorphisms in CDKN2A exons 2 and 3 made possible the expression analysis of this gene in heterozygous individuals. In addition the expression of the alternate transcript p16b could also be analysed because it shares exons 2 and 3 with CDKN2A. The alternate transcript p16b is of interest because it is a potent growth inhibitor in both mice and human cell lines (Quelle et al., 1995; Liggett et al., 1996) , it has an unusual genomic structure , it lies adjacent to CDKN2A on chromosome 9p21 and it is coregulated with p16 INK4a by pRb (Hara et al., 1996) . Furthermore, several melanoma-associated mutations in CDKN2A also aect the amino acid sequence of the predicted human protein encoded by the p16b transcript and may impair its function.
In most informative cases, we found that the relative expression of the p16
INK4a transcripts was very similar to that of the p16b transcripts, suggesting that their expression may be regulated coordinately. Although these genes have been shown to have independent promoter sequences it is possible that other cis-acting sequences independently co-regulate their expression. Functionally-related colocalised genes are often transcriptionally co-regulated and this may be due to common enhancer sequences that bind particular transcription factors (Brown et al., 1993; Colombo et al., 1992 ; GoÈ decke et al., 1991; Jones et al., 1995) . If the enhancer sequence on each chromosome is identical then the alleles of both genes would express equally well and this was the case in the majority of individuals we tested. Alternatively, an enhancer sequence on one chromosome may be more active, resulting in the dominance of the p16
INK4a and p16b alleles from one parental chromosome, as in 058 for example.
The tight co-regulation of the p16 INK4a and p16b transcripts was disrupted in three aected individuals belonging to two putative 9p-linking Australian melanoma kindreds that do not carry any CDKN2A exonic mutations (Holland et al., 1995) . With this type of analysis it is impossible to determine which gene and which allele is expressed abnormally. However, if the disruption in regulation of these 9p21 linked genes is involved with melanoma predisposition in these families then in all three cases it is either (i) the p16b allele from the aected parent that is down-regulated or (ii) the p16
INK4a allele from the aected parent that is upregulated. This could mean that the relevant cisacting enhancer element is somehow disrupted and stimulates p16
INK4a transcription more eectively than p16b transcription. Alternatively the enhancer may be functional but the down-regulated p16b allele may have a damaged promoter. A change in the stability of the p16b transcript is also a possible explanation for the reduced allele expression. Considering, however, that p16b shares important mRNA stabilising 3'-noncoding sequences with the p16
INK4a transcript, that no sequence changes were identi®ed in the coding regions and that all splice junctions were intact, this explanation seems unlikely.
Unequal allelic expression has been reported in relation to other genetic associations of cancer. The allelic messages of the neuro®bromin gene were found to be unequally expressed in 13/16 patients from families prone to neuro®bromatosis type 1. The under representation of one NF1 allelic message was due to a cytoplasmic post-transcriptional event (Homeyer et al., 1995) . Allele speci®c inactivation of Rb (Sakai et al., 1991) and CDKN2A Otterson et al., 1995) via methylation is also a common inactivation event. The N-ras oncogene was also found to display allelic imbalance in some myeloid leukaemic cells and cell lines, where the mutant N-ras message was often overexpressed, and in one instance underexpressed compared to the wild-type allele (LuÈ bbert et al., 1992) .
The inverse relationship between the expression of p16
INK4a and the presence of functional pRb has been described in detail (Li et al., 1994; Lukas et al., 1995; Shapiro et al., 1995; Yeager et al., 1995) and recently the pRb-responsive element in the CDKN2A promoter was mapped (Hara et al., 1996) . In addition in human ®broblasts expressing SV40 large T antigen both p16
INK4a and p16b were regulated by pRb (Khleif et al., 1996) . It is conceivable that pRb-binding transcription factors promote the expression of these colocalised genes. The transcription factor E2F-1 was found to upregulate a p16 like-sequence, possibly p16b, in keratinocytes (Khleif et al., 1996) . Another pRbbinding transcription factor perhaps even another E2F-factor may activate the expression of p16
INK4a
. The absence of an E2F consensus sequence in the CDKN2A promoter (Hara et al., 1996) does not exclude the possibility that E2F2 or 3 activates CDKN2A expression, since E2F-1 was shown to bind Figure 5 Sequence of CDKN2A exon 1b, starting at the ®rst intronic nucleotide (position c448; nucleotide numbering according to GDB-L41934). The underlined substitutions and doubleunderlined insertions compared with the published sequence were identi®ed by sequencing 11 independent chromosomes from seven individuals in ®ve kindreds to GC-rich elements and thus activate the herpes simplex virus thymidine kinase promoter (Shin et al., 1996) . Isolation of the p16b promoter, the analysis of CDKN2A and p16b promoter constructs and transfection experiments with candidate transcription factors will provide important information regarding the regulation of these two genes.
The p16 INK4a alternate transcript, p16b, is a unique growth suppressor. It utilises CDKN2A exonic sequences to produce a novel transcript and possibly a novel protein and is co-regulated with p16
INK4a by pRb. In addition, as shown in this study, the expression p16b and p16
INK4a are co-regulated in an allele-speci®c manner. This allele-speci®c co-regulation was disrupted in three melanoma prone-individuals that carried a 9p-haplotype segregating with melanoma in their respective two families. No CDKN2A or p16b exonic mutations have been detected in these two putative 9p-linking kindreds. This data suggests that loss of p16
INK4a and p16b co-regulation may lead to melanoma susceptibility. Further analysis will help clarify the contribution that disrupted regulation of p16
INK4a and/or p16b plays in melanocytic tumour progression and whether UV is a stimulus leading to the altered regulation of these two growth suppressors.
Materials and methods
Pedigree data
The kindreds studied here have been described elsewhere (Keord et al., 1991; Nancarrow et al., 1993) . Only the key features of the pedigrees are shown in Figure 2 to preserve con®dentiality, however all aected individuals and all those heterozygous for CDKN2A polymorphisms are shown.
Choice of cell lines
In this study the p16
INK4a and p16b RNA was reverse transcribed and ampli®ed from extracts of EBV-transformed lymphoblastoid cell lines. Although these cell lines are virally transformed and maintained in culture for a limited time, they were the only source available for p16
INK4a and p16b message from melanoma-prone kindreds. Further, the reproducibility of the results presented in this work and the concordant results obtained from individuals with identical 9p haplotypes (individuals: 1122 and 1124; 673 and 958, see Table 2 ) show that the data obtained from these cell lines are reliable and reproducible.
Attempts were also made to isolate and amplify p16
INK4a and p16b cDNA from peripheral blood lymphocytes and lymphocytes stimulated with phytohemaglutinin-A and interleukin 2. In both cases the level of p16 INK4a message was too low to permit analysis (data not shown).
Cell culture and 5-aza 2'-deoxycytidine drug treatment EBV-transformed lymphoblastoid cell lines were maintained in RPMI-1640 medium supplemented with 15% fetal bovine serum in a 378C incubator with 5% CO 2 . Unless otherwise stated, cell lines were extracted in triplicate each at a dierent passage number and all during exponential phase of growth. For demethylation experiments, EBV-transformed lymphoblastoid cells in log phase were exposed from 18 h after passaging to 1 mM 5-aza 2'-deoxycytidine (Sigma). Medium was replaced with fresh drug every 24 h for a total of 48 ± 72 h. For each cell line tested, RNA was extracted from one 5-aza 2'-deoxycytidine treated and one mock treated culture.
RNA preparation and reverse transcription
Total cellular RNA was prepared from EBV-transformed lymphoblastoid cell lines using the TRI-Reagent (MRC) following the manufacturer's protocol. After precipitation the RNA was treated with 5U RNase-free RQ1 DNase I (Promega) for 30 ± 60 min at 378C and reprecipitated. Subsequently 3 mg of total RNA and 0.18 mg of a speci®c p16 INK4a exon 3 primer (5'-CAGTGAAAAGGCA-GAAGCG-3') were mixed in a total volume of 12 ml, heated to 708C for 10 min and snap chilled. Reverse transcription was carried out using 50 U MMLV reverse transcriptase (USB) and 200 mM dNTPs in a 20 ml reaction volume for 60 min at 378C.
PCR and sequencing
To determine the allele speci®c expression of p16
INK4a and p16b, 0.2 ml of the reverse transcriptase reaction was ampli®ed in a 10 ml PCR reaction volume using either p16
INK4a or p16b speci®c primers. Ampli®cation was carried out using 1 mM MgCl 2 , 5% DMSO, 20 mM dNTPs, 1 mCi[a 33 P]-dATP (Amersham) and 0.5 U Taq DNA polymerase (USB). The PCR conditions were one cycle at 958C (5 min); 28 cycles at 958C (30 s), 528C (20 s) and 728C (40 s) followed by one cycle at 728C (10 min). The p16
INK4a
forward and reverse primers were 123A, (5'-GCAGCATGGAGCCTTCG-3') and 3B (5'-AAAACTAC-GAAAGCGGG-3') respectively. The p16b forward and reverse primers were p16b.fwd (5'-GGAATTC-GAGTGGCGCTGCTCACCTC-3') and 3B respectively.
In this type of PCR two essentially identical sequences are ampli®ed, so the allele products serve as internal standards for each other. Errors arising from the formation of heteroduplexes during PCR are also eliminated in this analysis, because the heteroduplexes are easily separated and distinguished from the homoduplex bands using TGGE. The reliability of the method was veri®ed by mixing various dilutions of two cDNA preparations. The cDNAs were generated from two individuals homozygous for either G 482 or T 580 . The relative amount of each allele product obtained had a linear relationship to the relative amount of each cDNA standard present in the ampli®cation reaction (data not shown). The method was also evaluated by performing PCR with serial dilutions of the 001 cDNA mix. The ratios obtained using at least three serial dilutions for the common p16 INK4a and p16b alleles were 0.45+0.05 and 0.50+0.04 respectively.
To permit sequencing of the p16b cDNA, 1 ml of the reverse transcriptase reaction was ampli®ed in a 50 ml reaction volume essentially as described above. Amplification of exon 1b was performed using the p16b.fwd and p16b.rev (5'-GAAGCTCTGTTCGCCTCAGT-3') primers. PCR products were puri®ed by polyethylene glycol precipitation and sequenced using dye-labelled automated cycle sequencing on an ABI 373 sequencer.
TGGE
Radioactively labelled PCR products were separated using temperature gradient gels consisting of 5% polyacrylamide (29:1), 8.5 M urea, 20 mM MOPS and 1 mM EDTA. Gels were run using a Qiagen TGGE apparatus usually for 4 h at 300 V. Temperature conditions used to separate the G 482 A (Ala148Thr) polymorphism and the C 580 T polymorphism were approximately 53.5 ± 54.58C and 49 ± 618C respectively. After electrophoresis, the gels were ®xed in 10% methanol and 10% acetic acid, vacuum dried and the band intensities were determined by densitometric measurements with a phosphoimager (Molecular Dynamics).
